ArticleApplied biosafety : journal of the American Biological Safety Association2025
Dual-Use Research and Publication Policies: A Comparison of Journals in Life Sciences and Artificial Intelligence.
Article in Applied biosafety : journal of the American Biological Safety Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Dual-use research (DUR) describes research with potential benefits that could be misapplied for harm. Policy on DUR is often limited to life sciences research. However, recently, there have been demonstrations of how research with dual-use concerns may extend beyond the life sciences to artificial intelligence (AI). One method of ensuring that research with dual-use concerns is not misapplied for harm is by censoring scientific journal articles. Journals may have policy on managing article submissions with potential DUR concerns. This study compared the policies of life science and AI journals toward DUR. Methods: Google Scholar Metrics and Scimago Journal and Country Rank were utilized to identify and select the top 20 publications in fields of life sciences and AI by specific metrics. The publicly accessible websites of each journal were searched to ascertain their publication policies regarding DUR. Journals and/or publishers were contacted if no policy was located. Results: From Google Scholar, 12/20 journals within the "Life Sciences & Earth Sciences" category had policies on DUR; from Scimago, 9/16 of the "Biochemistry, Genetics, and Molecular Biology" category had policies; and 8/19 of the "Immunology and Microbiology" category had policies. For AI journals, 2/13 journals from Google Scholar had policies; 4/15 journals from Scimago had policies. Conclusion: More journals in the life sciences have extant policies on how to handle article submissions with DUR concerns. Very few AI journals have policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.